Targeting NKG2D Ligands is Therapeutically Effective in NSCLC
07:30am - 03:45pm EDT - March 31, 2023
07:30am - 03:45pm EDT - March 31, 2023
Author(s):
- Dr Esra Akbay, PhD, Assistant Professor, UT Southwestern Simmons Comprehensive Cancer Center
Tags: Member Institution Pre-Clinical Oncology NCCN Foundation Young Investigator Award
| Display Label | Action |
|---|---|
| NCCN poster Akbay.pdf | Download Handout |
| AC23P01 - Targeting NKG2D Ligands is Therapeutically Effective in NSCLC | Download MP3 |
